3 Biotech Stocks That Soared This Week: Are They Buys?
There's nothing like good results from a clinical study to light a fire beneath a biotech stock. That's what has happened with several biotechs over the last few days.
Madrigal Pharmaceuticals (NASDAQ: MDGL), Spectrum Pharmaceuticals (NASDAQ: SPPI), and Zogenix (NASDAQ: ZGNX) reaped the rewards from recent announcements of clinical results for their respective products, with all three biotech stocks soaring this week. Here are the catalysts driving each stock higher -- and more important, a look at whether or not the biotech stocks are smart picks for investors.
Image source: Getty Images.
Source: Fool.com
Spectrum Pharmaceuticals Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Spectrum Pharmaceuticals stock is not clear.
With a target price of 1 € there is a slightly positive potential of 5.26% for Spectrum Pharmaceuticals compared to the current price of 0.95 €.